Why the study?
Does exogenous IFN treatment restrict human rotavirus replication in human intestinal enteroids?
Population
Nontransformed human intestinal enteroid cultures from multiple individuals infected with human rotavirus
Comparison
Exogenous interferon treatment vs Endogenous response / untreated
Design
Preclinical
Authors
Loading...
Human enteroid data indicate type I IFN outperforms type III in restricting rotavirus; leaves open whether extraepithelial sources drive intestinal antiviral defense.
Does exogenous IFN treatment restrict human rotavirus replication in human intestinal enteroids?
Type I interferon is more potent than type III interferon in restricting human rotavirus replication in human intestinal enteroids, suggesting extraepithelial sources of type I IFN are critical for limiting enteric virus replication.
Saxena et al. (2017) studied this question.